Mediclinic completes R5bn rights issue

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Mediclinic completes R5bn rights issue

Mediclinic’s R5bn ($568m) rights issue was 99.7% subscribed, the company said on Monday. The South African private healthcare company, which is listed on the Johannesburg Stock Exchange, will use proceeds from the deal to support a R28bn loan refinancing.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article